Healthcare provider profile · identity verified

Russell Bell, DO

Family Practice · LINDALE, TX · NPI 1568465755

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	629	187
Atorvastatin Calcium	Atorvastatin Calcium	434	139
Lisinopril	Lisinopril	374	118
Montelukast Sodium	Montelukast Sodium	330	132
Levothyroxine Sodium	Levothyroxine Sodium	329	97
Pantoprazole Sodium	Pantoprazole Sodium	292	94
Gabapentin	Gabapentin	285	84
Losartan Potassium	Losartan Potassium	273	91
Metformin Hcl	Metformin Hcl	273	79
Rosuvastatin Calcium	Rosuvastatin Calcium	231	79
Doxazosin Mesylate	Doxazosin Mesylate	203	61
Tamsulosin Hcl	Tamsulosin Hcl	199	60
Hydralazine Hcl	Hydralazine Hcl	189	59
Glimepiride	Glimepiride	175	56
Simvastatin	Simvastatin	159	50
Metoprolol Succinate	Metoprolol Succinate	155	51
Omeprazole	Omeprazole	153	47
Potassium Chloride	Potassium Chloride	153	46
Carvedilol	Carvedilol	152	45
Tizanidine Hcl	Tizanidine Hcl	152	73
Duloxetine Hcl	Duloxetine Hcl	147	50
Hydrochlorothiazide	Hydrochlorothiazide	139	50
Lovastatin	Lovastatin	134	42
Sertraline Hcl	Sertraline Hcl	132	44
Tramadol Hcl	Tramadol Hcl	129	40
Fluticasone Propionate	Fluticasone Propionate	127	37
Furosemide	Furosemide	116	38
Pravastatin Sodium	Pravastatin Sodium	112	29
Olmesartan Medoxomil	Olmesartan Medoxomil	109	31
Finasteride	Finasteride	108	32
Metoprolol Tartrate	Metoprolol Tartrate	106	36
Zolpidem Tartrate	Zolpidem Tartrate	98	17
Allopurinol	Allopurinol	94	30
Hydroxyzine Hcl	Hydroxyzine Hcl	94	28
Albuterol Sulfate Hfa	Albuterol Sulfate	93	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	19
Alprazolam	Alprazolam	90	23
Meloxicam	Meloxicam	88	36
Temazepam	Temazepam	88	15
Irbesartan	Irbesartan	87	23
Fluoxetine Hcl	Fluoxetine Hcl	86	28
Clonazepam	Clonazepam	84	20
Escitalopram Oxalate	Escitalopram Oxalate	79	29
Trazodone Hcl	Trazodone Hcl	74	32
Ezetimibe	Ezetimibe	67	21
Valsartan	Valsartan	66	19
Cefdinir	Cefdinir	61	55
Lorazepam	Lorazepam	60	15
Fenofibrate	Fenofibrate	50	14
Synthroid	Levothyroxine Sodium	50	12
Clopidogrel	Clopidogrel Bisulfate	49	14
Famotidine	Famotidine	47	18
Citalopram Hbr	Citalopram Hydrobromide	43	16
Azelastine Hcl	Azelastine Hcl	41	17
Eliquis	Apixaban	41	11
Prednisone	Prednisone	40	34
Atenolol	Atenolol	39	13
Jardiance	Empagliflozin	39	12
Methylprednisolone	Methylprednisolone	39	38
Nifedipine Er	Nifedipine	39	14
Diclofenac Sodium	Diclofenac Sodium	38	19
Celecoxib	Celecoxib	36	suppressed
Spironolactone	Spironolactone	35	suppressed
Lactulose	Lactulose	34	suppressed
Myrbetriq	Mirabegron	33	suppressed
Alendronate Sodium	Alendronate Sodium	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Glipizide	Glipizide	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	26
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	16
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Cephalexin	Cephalexin	24	21
Chlorthalidone	Chlorthalidone	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Ondansetron Odt	Ondansetron	22	12
Ramipril	Ramipril	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Bupropion Xl	Bupropion Hcl	21	suppressed
Methocarbamol	Methocarbamol	21	11
Premarin	Estrogens, Conjugated	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Nystatin	Nystatin	20	11
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Topiramate	Topiramate	18	suppressed
Diazepam	Diazepam	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Estradiol	Estradiol	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Constulose	Lactulose	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Azithromycin	Azithromycin	12	12
Januvia	Sitagliptin Phosphate	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error